Quintrio
Home

SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

bioAffinity Technologies, Inc. Common Stock

BIAF

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

Last trade $2.00
Day change $0.00 (0.00%)
Day range $1.95 – $2.13
Volume 39,403
Market cap $4M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$3.64M
Price / earnings
—
Price / book
0.93×
Price / sales
0.66×
EV / sales
0.33×
EV / EBITDA
-0.14×

Profitability

Earnings per share
-$8.47
Return on assets
-204.02%
Return on equity
-393.69%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.19×
Current ratio
1.51×
Quick ratio
1.47×
Cash ratio
1.01×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$13.03M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for BIAF, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$1.07M$1.51M$1.35M$1.59M$1.45M$1.27M$1.85M$2.21M
Cost of revenue$0$0$0$900.13K$0$0$0$1.56M
Gross profit$1.07M$1.51M$1.35M$692.69K$1.45M$1.27M$1.85M$645.43K
Selling, general and administrative$2.76M$2.86M$3.24M$3.04M$2.21M$2.21M$2.45M$2.92M
Research and development$640.17K$837.46K$683.75K$668.81K$473.9K$440.65K$505.74K$518.19K
Total operating expenses$4.58M$4.85M$4.97M$3.83M$3.74M$3.79M$4.48M$3.59M
Operating income-$3.51M-$3.33M-$3.62M-$3.14M-$2.29M-$2.52M-$2.63M-$2.95M
Interest expense-$10.71K-$11.69K-$14.72K-$13.07K-$5.36K-$10.46K-$15.49K-$25.05K
Income before taxes-$5.28M-$3.37M-$3.63M-$3.13M-$5.05M-$4.03M-$2.65M-$2.97M
Income taxes$0$0$0$3.18K$3.18K$28.98K$8.7K$0
Net income-$5.28M-$3.37M-$3.63M-$3.14M-$5.05M-$4.06M-$2.66M-$2.97M
Net income attributable to common shareholders-$5.28M-$3.37M-$3.63M-$3.14M-$5.05M-$4.06M-$2.66M-$2.97M
EBITDA-$3.44M-$3.27M-$3.5M-$3.01M-$2.18M-$2.4M-$2.47M-$2.79M
Basic earnings per share-$5.89-$9.60-$12.15—-$71.05-$76.05-$2.40-$90.17
Diluted earnings per share-$5.89-$9.60-$12.15—-$71.05-$76.05-$2.40-$90.17

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

BIAF Stock Dips Post Q3 Earnings Despite Rising Test Demand, Sales Down

bioAffinity Technologies (BIAF) stock fell 10% following Q3 2026 earnings, underperforming the S&P 500's 3.4% gain. While CyPath Lung test unit sales surged 100% year-to-date and physician adoption increased 89%, quarterly revenues declined 25.9% to $1.1 million due to lower reimbursement rates and reduced testing volumes. The company reported a widened net loss of $5.3 million and faces going concern doubts, with cash resources expected to last only through March 2027 without additional financing.

Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Kidpik Corp. (NASDAQ: PIK) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares surged 149% to $2.6450. TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share. Fangdd Network Group Ltd. (NASDAQ: DUO) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. GDS Holdings Limited (NASDAQ: GDS) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business. Solidion Technology Inc. (NASDAQ: STI) rose 23.3% to $0.9620. Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024. EHang Holdings Limited (NASDAQ: EH) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024. Bally's Corporation (NYSE: BALY) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company. Rail Vision Ltd. (NASDAQ: RVSN) climbed 21.2% to $3.43. Rail Vision ...

Benzinga

Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.20% to 38,662.69 while the NASDAQ rose 0.64% to 16,041.08. The S&P 500 also rose, gaining, 0.53% to 5,105.72. Check This Out: Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday   Leading and Lagging Sectors   Information technology shares jumped by 1.1% on Wednesday. In trading on Wednesday, consumer discretionary shares fell 0.3%.   Top Headline   Campbell Soup Company (NYSE: CPB) reported better-than-expected earnings for its second quarter. The company posted a second-quarter FY24 decline of 1.2% year-on-year to $2.46 billion, beating the analyst consensus estimate of $2.44 billion. Adjusted EPS of 80 cents beat the consensus estimate of 77 cents.   Equities Trading UP   Aptorum Group Limited (NASDAQ: APM) shares shot up 595% to $11.60 after the company announced it entered into an agreement and plan of merger with YOOV and also announced a spin-off agreement to separate its legacy business. Shares of TRxADE HEALTH, Inc. (NASDAQ: MEDS) got a boost, surging 112% to $17.06 after the company announced a special cash dividend of $8 per share. Rail Vision Ltd. (NASDAQ: RVSN) shares were also up, ...

Benzinga

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results. United Natural Foods posted adjusted earnings of 7 cents per share, compared to market estimates for a loss of 1 cent per share. The company’s quarterly sales came in at $7.78 billion, versus expectations of $7.87 billion, according to data from Benzinga Pro. United Natural Foods named Giorgio Matteo Tarditi as President and Chief Financial Officer. United Natural Foods shares dipped 15.2% to $12.61 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 115.2% to $4.24. Rail Vision announced first commercial installation of its AI-driven main line systems in a national railways line. Aptorum Group Limited (NASDAQ: APM) shares climbed 90.1% to $3.1750. Aptorum Group announced an agreement and plan of merger with YOOV Group Holding Ltd and a split-off agreement to separate its legacy business. NKGen Biotech, Inc. (NASDAQ: NKGN) gained 46.5% to $1.35. TRxADE HEALTH, Inc. (NASDAQ: MEDS) rose 39.2% to $11.19 after the company announced a special cash dividend of $8 per share. Airship AI Holdings, Inc. (NASDAQ: AISP) shares climbed 37.8% to $6.82. Airship AI Holdings shares jumped 200% on Tuesday after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform. Enviva Inc. (NYSE: EVA) rose 33% to $0.9854 after gaining 42% on Tuesday. American Public Education, Inc. (NASDAQ: APEI) gained 31.8% to $14.99 following upbeat quarterly results. Dada Nexus Limited (NASDAQ: DADA) climbed 30.6% to $2.5740. Dada Nexus said certain revenues and associated costs were overstated in past financial statements. Cemtrex, Inc. (NASDAQ: CETX) gained 30% to $4.4361. Cemtrex announced beta release of pioneering AI gun detection feature. Wave Life Sciences Ltd. (NYSE: WVE) gained 28.5% to $6.16 following upbeat quarterly results. Vincerx Pharma, Inc. (NASDAQ: VINC) shares gained 24.5% to $6.89. Vincerx will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024. XORTX Therapeutics Inc. (NASDAQ: XRTX) rose 24.2% to $5.85. CareMax, Inc. (NASDAQ: CMAX) gained 23.8% to ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Aug 24, 20261-for-15reverse split
Sep 19, 20251-for-30reverse split